Interaction magnitude, pharmacokinetics and pharmacodynamics of ticlopidine in relation to CYP2C19 genotypic statusIEIRI, Ichiro; KIMURA, Miyuki; IRIE, Shin et al.Pharmacogenetics and genomics (Print). 2005, Vol 15, Num 12, pp 851-859, issn 1744-6872, 9 p.Article

Hépatite granulomateuse et ticopidine = Granulomatous hepatitis and ticlopidineFLAMENBAUM, M; ZENUT, M; CASTILLO, D et al.Thérapie (Paris). 1997, Vol 52, Num 6, pp 610-611, issn 0040-5957Article

Non-bleeding side effects of clopidogrel : Have large multi-center clinical trials underestimated their incidence?ALMSHERQI, Zakaria A; MCLACHLAN, Craig S; SHAREF, Sadik M et al.International journal of cardiology. 2007, Vol 117, Num 3, pp 415-417, issn 0167-5273, 3 p.Article

Clopidogrel and ticlopidine: P2Y₁₂ adenosine diphosphate-receptor antagonists for the prevention of atherothrombosisSAVI, Pierre; HERBERT, Jean-Marc.Seminars in thrombosis and hemostasis. 2005, Vol 31, Num 2, pp 174-183, issn 0094-6176, 10 p.Article

Antithrombic drugsFLEMING, J. S; BUYNISKI, J. P; BRUNO, J. J et al.New drugs annual: cardiovascular drugs. 1983, Vol 1, pp 277-316Article

Inhibitory effects of ticlopidine on platelet function as assessed by three different methodsCUYUN-LIRA, O; KANEKO, M; TAKAFUTA, T et al.European journal of pharmaceutical sciences. 2007, Vol 30, Num 1, pp 21-25, issn 0928-0987, 5 p.Article

Analytical approach to determine ticlopidine in post-mortem bloodBARROSO, M; GALLARDO, E; MARGALHO, C et al.Forensic science international. 2006, Vol 162, Num 1-3, pp 121-125, issn 0379-0738, 5 p.Conference Paper

Poor responsiveness to clopidogrel : Drug-specific or class-effect mechanism? evidence from a clopidogrel-to-ticlopidine crossover studyCAMPO, Gianluca; VALGIMIGLI, Marco; PARRINELLO, Giovanni et al.Journal of the American College of Cardiology. 2007, Vol 50, Num 12, pp 1132-1137, issn 0735-1097, 6 p.Article

Effects of policosanol and ticlopidine in patients with intermittent claudication: A double-blinded pilot comparative studyCASTANO, Gladys; MAS, Rosa; GAMEZ, Rafael et al.Angiology. 2004, Vol 55, Num 4, pp 361-371, issn 0003-3197, 11 p.Article

Probable interaction between cyclosporin A and low dose ticlopidineVERDEJO, A; DE COS, M. A; ZUBIMENDI, J. A et al.BMJ. British medical journal (International ed.). 2000, Vol 320, Num 7241, issn 0959-8146, p. 1037Article

Liquid chromatographic method for the determination of ticlopidine in human plasmaRONA, K; ARY, K; GACHALYI, B et al.Journal of chromatography. B, Biomedical sciences and applications. 1997, Vol 693, Num 2, pp 393-398, issn 1387-2273Article

How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modificationNEUBAUER, Horst; LASK, Sebastian; ENGELHARDT, Andreas et al.Thrombosis and haemostasis. 2008, Vol 99, Num 2, pp 357-362, issn 0340-6245, 6 p.Article

New antiplatelet agents: ticlopidine and clopidogrel. Antiplatelet therapy but at what cost?BLACK, Corrinda; PATERSON, Kenneth R.Adverse drug reactions and toxicological reviews. 2001, Vol 20, Num 4, pp 277-303, issn 0964-198XArticle

Unusual effects of aspirin on ticlopidine induced thrombolysisGRYGLEWSKI, R. J; URACZ, W; SWIGS, J et al.Thorax. 2000, Vol 55, pp S17-S19, issn 0040-6376, SUP2Conference Paper

Ticlopidine and platelet functionLECOMPTE, T; LECRUBIER, C; POTEVIN, F et al.Thrombosis and haemostasis. 1986, Vol 55, Num 3, issn 0340-6245, 437Article

Ticlopidine and platelet function ― rejoinderBERGLUND, U; WALLENTIN, L.Thrombosis and haemostasis. 1986, Vol 55, Num 3, issn 0340-6245, 438Article

Quantitative Determination of Ticlopidine Hydrochloride in Human Plasma by High-performance Liquid Chromatography-Electronspray Ionization Mass SpectrometryJING SUN; HAOYAN JIAO; YUAN TIAN et al.Arzneimittel-Forschung. 2009, Vol 59, Num 3, pp 121-128, issn 0004-4172, 8 p.Article

Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout miceJAWIEN, Jacek; CSANYI, Gabor; GAJDA, Mariusz et al.European journal of pharmacology. 2007, Vol 556, Num 1-3, pp 129-135, issn 0014-2999, 7 p.Article

The prevention of minor myocardial injury with ticlopidine pretreatment in patients undergoing elective coronary stentingATMACA, Yusuf; GÜLEC, Sadi; ERTAS, Fatih et al.International journal of cardiology. 2003, Vol 87, Num 2-3, pp 151-157, issn 0167-5273, 7 p.Article

Ticlopidine-induced hepatotoxicity in a GSH-depleted rat modelSHIMIZU, Shinji; ATSUMI, Ryo; NAKAZAWA, Tsunenori et al.Archives of toxicology. 2011, Vol 85, Num 4, pp 347-353, issn 0340-5761, 7 p.Article

Probucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetesNOMURA, Shosaku; TAKAHASHI, Nobuyuki; INAMI, Norihito et al.Atherosclerosis. 2004, Vol 174, Num 2, pp 329-335, issn 0021-9150, 7 p.Article

DEUX OBSERVATIONS D'AGRANULOCYTOSE AIGUE AU COURS D'UN TRAITEMENT ANTI-AGREGANT PAR LA TICLOPIDINECHOMIENNE C; BAUMELOU E; RIO B et al.1983; REVUE DE MEDECINE (PARIS); ISSN 0035-1512; FRA; DA. 1983; VOL. 24; NO 13; PP. 589-590; ABS. ENG; BIBL. 3 REF.Article

COMPARISON BETWEEN THE ANTIAGGREGATINE EFFECT OF TICLOPIDINE IN WHOLE BLOOD, PLATELET-RICH PLASMA AND WASHED PLATELETS OF THE RATRANDON J; LEFORT J; VARGAFTIG BB et al.1982; THROMBOSIS RESEARCH; ISSN 0049-3848; USA; DA. 1982; VOL. 26; NO 1; PP. 13-20; BIBL. 19 REF.Article

Hemorheological effect of ticlopidine in the ratONO, S.-E; ASHIDA, S.-I; ABIKO, Y et al.Thrombosis research. 1983, Vol 31, Num 4, pp 549-556, issn 0049-3848Article

Ticlopidine activity on platelet function in patients with enhanced platelet aggregation: a short-term crossover studyGENSINI, G. F; FAVILLA, S; BRESCHI, C et al.Haemostasis. 1983, Vol 13, Num 5, pp 294-300, issn 0301-0147Article